Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder

International Journal of Urology

Volumn 8, Issue 9, 2001, Pages 483-486

  Sekine, Hideaki ^a   Ohya, Kazuhiro ^a   Kojima, Sin Ichi ^a   Igarashi, Kazumasa ^b   Fukui, Iwao ^c  

^a TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

^b Nissan Tamagawa Hospital   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Bladder neoplasms; Carcinoma in situ; Histology; Intravesical therapy

Indexed keywords

BCG VACCINE; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG INSTILLATION; DRUG RESPONSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL TREATMENT;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 0034790357     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2001.00355.x     Document Type: Article

References (11)

1. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder
2. Histological grading of carcinoma in situ of the bladder: Its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy
3. Carcinoma in situ of the bladder
4. Superficial bladder cancer treated with bacillus Calmette-Guerin: A multivariate analysis of factors affecting tumor progression
5. Outcome in carcinoma in situ of bladder treated with intravesical bacille Calmette-Guerin
6. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression
7. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder
8. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns
9. Over-expression of p53 and its significance for recurrent progressive bladder tumors
10. Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor, and bcl-2
11. Over-expression of the p53 nuclear oncoprotein in transitional cell carcinoma of the bladder and its prognostic value